DV
Dividend Vision

CNSP — CNS Pharmaceuticals Inc

CNS Pharmaceuticals Inc (CNSP)

Total return is -100.0% over the past 6.8 years, 277.0 points behind SPY at 177.0%. Its deepest 1-year drawdown was 79.8%.

CNSP is an equity stock focused on the pharmaceutical sector. With no disclosed distribution rate or expense ratio data available, this holding does not appear to be structured as a traditional dividend-paying ETF. The limited fund documentation suggests this may be a single-stock position or specialized pharmaceutical equity vehicle rather than a diversified dividend strategy suited for income-focused investors.

CNSP key facts

Asset type
Stock
Asset class
Equity
Inception date
11/08/2019
Last close
$5.52
Market cap
$7,365,703
Average volume
6700.0
Beta
1.024
Payout ratio
0.0
Forward P/E
0.0
EPS
$-24.12